NKTR
Nektar Therapeutics · Healthcare
General Counsel Mark Andrew Wilson sold $31K of Nektar Therapeutics
Sold$31,023
$3.57Price
8,690Shares
−3%Stake
What NKTR did after the filing
- The stock from Fri, Nov 18 close, $52.35
- −33.0%
- S&P 500, same days
- −2.7%
Measured over 30 trading days, to the Jan 4 close.
Traded Wed, Nov 16. Filed Fri, Nov 18, 1:04 PM ET, during the session. Returns use the Nov 18 close and the Jan 4 close. Not investment advice.